Water-Soluble Pristine C₆₀ Fullerenes Inhibit Liver Fibrotic Alteration and Prevent Liver Cirrhosis in Rats

Table 2

Liver and plasma blood biochemical parameters for rats that experienced DEN+CCl₄ fibrosis and cirrhosis and treated by C₆₀FAS.

Parameters	10 weeks			15 weeks
	Control	Fibrosis	Fibrosis+C60FAS	Control	Cirrhosis	Cirrhosis+C60FAS
Bilirubin conjugated (μmol/l)
Bilirubin nonconjugated (μmol/l)
ALT (μmol/ml per h)
AST (μmol/ml per h)
ALP (μmol/ml per h)
LDH (U/l)
Urea (mmol/l)
Creatinine (μmol/l)
α-Amylase (g/l per h)
SOD (U/mg protein)
CAT (mol/mg protein)
GSH (nmol/mg protein)
GST (μmol/mg protein)
GP (nmol/mg protein)
MDA (μmol/mg protein)
PCG (μmol/mg protein)

compared to control; compared to the fibrosis/cirrhosis group.